Sarcopenia & Frailty Syndrome
These are some of the conditions which pose significant challenges to healthy aging, highlighting the need for early detection, balanced nutrition, consistent exercise, and holistic care to sustain quality of life and independence.
Sarcopenia
Sarcopenia is a progressive and generalized skeletal muscle disorder characterized by the loss of muscle mass, strength, and function. It is commonly associated with aging and can significantly impact an individual's quality of life.
The condition not only leads to physical decline but also increases the risk of falls, fractures, and overall frailty. Sarcopenia is influenced by a combination of factors, including decreased physical activity, hormonal changes, inadequate nutrition, and chronic diseases.
Frailty Syndrome
Frailty Syndrome is a clinical condition, often overlapping with sarcopenia, marked by reduced physiological reserve and increased vulnerability to stressors.
Frailty typically involves multiple systems and manifests through symptoms such as weakness, slowed movement, weight loss, exhaustion, and low physical activity. Like sarcopenia, frailty is prevalent among the elderly and can lead to adverse health outcomes, including increased hospitalization, disability, and mortality.
Both sarcopenia and frailty are critical aspects of geriatric health, necessitating early detection and comprehensive management strategies to improve the well-being and independence of older adults.
European Union Trusts Our Expertise in Pioneering Health Innovations
In 2023, our company, renowned for its cutting-edge research and innovative solutions, successfully concluded a groundbreaking project titled "Innovative Application of Biologically Active Elements for Cardiovascular Support and Prevention of Sarcopenia - A Project of Healthy Aging." This ambitious initiative, generously financed by the European Union, underscores the EU's trust in our expertise and commitment to advancing public health.
Our scientific team embarked on this project with the aim of addressing two critical aspects of aging: sarcopenia and cardiovascular health. Through rigorous research and experimentation, detailed in the "Science" section of our website, we explored the synergistic effects of biologically active elements on these conditions. The extensive scientific material available includes links to experiments and peer-reviewed articles, demonstrating the thoroughness and transparency of our approach.
The culmination of this project is the development of the world's first supplement designed to combat sarcopenia while providing synergistic support for cardiovascular function. This supplement represents a significant leap forward in the field of healthy aging, with its efficacy and safety firmly grounded in scientific evidence. The phrase "proven by science" truly applies, as our findings have been validated through meticulous research and experimentation.
This innovative supplement not only exemplifies our commitment to improving quality of life for the aging population but also highlights the critical role of the European Union in supporting pioneering health initiatives. By investing in our expertise, the EU has enabled the creation of a scientifically validated solution that addresses two of the most pressing health challenges faced by older adults today.